GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Ending Cash Position

Intravenous Infusions (XGHA:IIL) Ending Cash Position : GHS0.00 Mil (As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Ending Cash Position?

Intravenous Infusions's Ending Cash Position for the quarter that ended in . 20 was GHS0.00 Mil.


Intravenous Infusions Ending Cash Position Historical Data

The historical data trend for Intravenous Infusions's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Ending Cash Position Chart

Intravenous Infusions Annual Data
Trend
Ending Cash Position

Intravenous Infusions Semi-Annual Data
Ending Cash Position

Intravenous Infusions Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Intravenous Infusions's Ending Cash Position for the fiscal year that ended in . 20 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=+
=0.00

Intravenous Infusions's Ending Cash Position for the quarter that ended in . 20 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=+
=0.00


Intravenous Infusions Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Intravenous Infusions (XGHA:IIL) Business Description

Traded in Other Exchanges
N/A
Address
Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.